Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Cancer Research|April 5, 2005
The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?Jürgen C Becker, Per thor Straten, Mads Hald Andersen
Nature Reviews. Drug Discovery|May 3, 2005
Regulators of apoptosis: suitable targets for immune therapy of cancerMads Hald Andersen, Jürgen C Becker, Per thor Straten
Cancer Immunology, Immunotherapy : CII|October 31, 2019
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targetingMarlies J W Peeters, Anne Rahbech, Per Thor Straten
Cancer Immunology, Immunotherapy : CII|December 26, 2013
Self-reactive T cells: suppressing the suppressorsJürgen C Becker, Per thor Straten, Mads Hald Andersen
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"Rikke Baek Sørensen, Per thor Straten, Mads Hald Andersen
The Journal of Investigative Dermatology|May 14, 2004
Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAPMads Hald Andersen, Jürgen C Becker, Per thor Straten
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2Manja Idorn, Per Thor Straten, Inge Marie Svane, et al.
Immunology Letters|October 8, 2025
The cancer-immunity cycle in motion: The effects of exercise on antitumor immunityKatharina Leuchte, Maike Trommer, Gitte Holmen Olofsson, et al.
Journal of Skin Cancer|July 21, 2011
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical applicationNiels Junker, Per Thor Straten, Mads Hald Andersen, et al.
Scandinavian Journal of Gastroenterology|January 5, 2012
Immunotherapy for metastatic colorectal cancer: present status and new optionsEva Ellebaek, Mads Hald Andersen, Inge Marie Svane, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Cancer Research|April 5, 2005
The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?Jürgen C Becker, Per thor Straten, Mads Hald Andersen
Nature Reviews. Drug Discovery|May 3, 2005
Regulators of apoptosis: suitable targets for immune therapy of cancerMads Hald Andersen, Jürgen C Becker, Per thor Straten
Cancer Immunology, Immunotherapy : CII|October 31, 2019
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targetingMarlies J W Peeters, Anne Rahbech, Per Thor Straten
Cancer Immunology, Immunotherapy : CII|December 26, 2013
Self-reactive T cells: suppressing the suppressorsJürgen C Becker, Per thor Straten, Mads Hald Andersen
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"Rikke Baek Sørensen, Per thor Straten, Mads Hald Andersen
The Journal of Investigative Dermatology|May 14, 2004
Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAPMads Hald Andersen, Jürgen C Becker, Per thor Straten
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2Manja Idorn, Per Thor Straten, Inge Marie Svane, et al.
Immunology Letters|October 8, 2025
The cancer-immunity cycle in motion: The effects of exercise on antitumor immunityKatharina Leuchte, Maike Trommer, Gitte Holmen Olofsson, et al.
Journal of Skin Cancer|July 21, 2011
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical applicationNiels Junker, Per Thor Straten, Mads Hald Andersen, et al.
Scandinavian Journal of Gastroenterology|January 5, 2012
Immunotherapy for metastatic colorectal cancer: present status and new optionsEva Ellebaek, Mads Hald Andersen, Inge Marie Svane, et al.
Pageof 18